ftInvstr
STAR · Healthcare ₹1000.1 -3.46% Mkt Cap ₹9251 Cr overvalued

STAR

Healthcare Drug Manufacturers - Specialty & Generic
₹1000.1
-3.46% today · 30d -7.4%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for STAR. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹1430 Cr
+17.11% YoY
NET PROFIT
₹134 Cr
+1.97% YoY
OPM
17.78%
-2.95pp YoY
EPS
₹14.19
PE 14.98
Intrinsic value · DCF ₹707.31 · Margin of safety -29.3% (overvalued) · FCF yield 3.02%
◇ Sector Position
PEERPEROCE %
STAR14.9819.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance POSITIVE 55
Valuation CHEAP 75
Growth MUTED 39
Profitability HIGH 78
Technicals WEAK 45
Risk LOW 90
Key Stats
TTM PE
14.98
P/B
2.7
52W HIGH
₹1260.9
OFF HIGH
-20.68%
DIV YIELD
0.5%
MKT CAP
₹9251 Cr
◉ Active Signals
MACDBearish-1.9682
RSI(14)Neutral40.29
Street Consensus
3 analysts
₹1304.67
mean target
Low ₹1254.0Now ₹1000.1High ₹1352.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold STAR and at what entry.

Sign up freeSign in